Related Experiment Videos
Experimental ocular malignant melanoma in Sinclair swine.
Current Eye Research
|April 1, 1986
Summary
Researchers developed an ocular melanoma model in swine, improving tumor take rates with triamcinolone acetonide. However, the model
Area of Science:
- Ophthalmology
- Oncology
- Veterinary Medicine
Background:
- Malignant melanoma of the eye presents significant treatment challenges.
- Developing reliable animal models is crucial for studying ocular tumors and testing therapies.
Purpose of the Study:
- To establish and evaluate an animal model for ocular malignant melanoma using swine.
- To assess the efficacy of subconjunctival triamcinolone acetonide in enhancing tumor engraftment.
Main Methods:
- Transplantation of cutaneous melanoma cell suspensions into the anterior chamber of miniature swine eyes.
- Administration of subconjunctival triamcinolone acetonide to assess its effect on tumor take frequency.
Main Results:
- Successful establishment of an ocular melanoma model in swine.
- Subconjunctival triamcinolone acetonide increased tumor take frequency from 8.9% to 22%.
- Challenges identified include sporadic tumor incidence, rapid glaucoma development, and obscured tumors due to iris pigmentation.
Conclusions:
- The swine model shows potential but has limitations for specific research applications.
- The model's utility for hematoporphyrin derivative-photoradiation treatment studies is questionable due to inherent drawbacks.